3 hours Immuneering Co. (NASDAQ:IMRX) Receives Average Rating of “Moderate Buy” from Brokerages MarketBeat
Shares of Immuneering Co. (NASDAQ:IMRX – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the seven brokerages that are presently covering the company, Marketbeat.com reports. Three analysts have rated the stock wi…